Nottingham City Hospital

Nottingham, Nottinghamshire NG56EG

0 studies enrolling now · 7 studies all time

What they study most

Advanced Cholangiocarcinoma, Anemia, Breast Cancer, Bronchiectasis, Carcinoma, Small Cell, FGFR2 Gene Mutation, Idiopathic Pulmonary Fibrosis (IPF), Myelofibrosis, Myeloproliferative Disorders, Post-Polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Refractory or Unexplained Chronic Cough

Studies at this site

• An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions — Running, not enrolling
• Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough — Running, not enrolling
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis — Completed
• Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer — Completed